Alimera Sciences, Inc. (Nasdaq: ALIM) announced that data from six ILUVIEN® post marketing studies were presented during the French Society ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE